MedPath

The effect of dydrogesterone and various forms of progesterone in support of artificial reproduction techniques

Phase 2
Conditions
Artificial fertilization.
Complications of attempted introduction of fertilized ovum following in vitro fertilization
Registration Number
IRCT2016010825902N1
Lead Sponsor
Vice chancellor For Research Of Ahvaz Jundishapur University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
159
Inclusion Criteria

Inclusion Criteria: Patients candidate for in vitro fertilization (IVF) or intracytoplasmic cytoplasmic sperm injection (ICSI); Having a normal uterus.

Exclusion Criteria

Abnormal uterus such as submucosal myoma and endometrial adhesions; Sensitivity to progesterone; Lack of fertilization; Having a systemic disease.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pregnancy. Timepoint: Once a week after embryo transfer into the patient. Method of measurement: The blood hCG test.;Preterm delivery. Timepoint: Every two weeks from the twentieth week of pregnancy. Method of measurement: Patient appointments and record uterine contractions.;Amount of live birth. Timepoint: Every two weeks from twenty-eighth week of pregnancy. Method of measurement: Patient appointments and record baby's birth.;Grade and the number of transferred embryo cells. Timepoint: Immediately before embryo transfer into the patient. Method of measurement: By using microscope.
Secondary Outcome Measures
NameTimeMethod
Perineal irritation caused by progesterone vaginal suppository. Timepoint: Every two weeks during treatment period. Method of measurement: Verbal questionnaire and the patient's response.
© Copyright 2025. All Rights Reserved by MedPath